Compare · SERM
Clomiphene vs Raloxifene
Both are serm compounds. Here's how they line up on the evidence — graded the same way.
| Clomiphene | Raloxifene | |
|---|---|---|
| Evidence | Strong human | Strong human |
| Class | SERM | SERM |
| Summary | Clomiphene is a selective estrogen receptor modulator (SERM), not a peptide, with strong human evidence that it raises testosterone in hypogonadal men while preserving fertility; male use is off-label, it is prescription-only, and it is banned in sport at all times. | Raloxifene is a selective estrogen receptor modulator (SERM) — an FDA-approved postmenopausal osteoporosis and breast-cancer-risk-reduction drug, not a peptide. Its defining serious risks are blood clots and fatal stroke; it is banned in sport at all times (WADA S4.2). |
| Full profile → | Full profile → |
Clomiphene
Clomiphene is one of those compounds that constantly gets lumped in with peptides and "research chemicals" in fitness circles, but it is neither. It is a selective estrogen receptor modulator — a small-molecule oral drug in the same chemical family as tamoxifen — and that distinction explains…
Raloxifene
Raloxifene, sold as Evista, is an oral, once-daily selective estrogen receptor modulator (SERM) — a legitimate, well-characterized prescription drug. It is important to be precise about what it is: raloxifene is not a peptide, not an aromatase inhibitor (which is a different anti-estrogen…